Coeptis Therapeutics' Partner Deverra Therapeutics Has Received Two Life Science Start-Up And Development Awards And Associated Grant from Washington's Cancer Research Endowment, Totaling Approximately $3.5M
Portfolio Pulse from Benzinga Newsdesk
Coeptis Therapeutics' partner, Deverra Therapeutics, has received two life science start-up and development awards and an associated grant from Washington's Cancer Research Endowment, totaling approximately $3.5M.
September 11, 2023 | 11:53 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Coeptis Therapeutics' partner, Deverra Therapeutics, has received significant funding, which could potentially benefit Coeptis in their partnership.
The funding received by Deverra Therapeutics could potentially be used in the development of projects that are part of the partnership with Coeptis Therapeutics. This could lead to advancements in their shared projects, potentially benefiting Coeptis and positively impacting their stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80